Colonial Trust Advisors
Position in SLS — SELLAS Life Sciences Group, Inc.
CIK 1567993
SPARTANBURG, SC
Position in SLS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$37,136
+$26,494 QoQ
Shares Held
2,516
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#156
of 189 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Colonial Trust Advisors holds $281,628 across 10 Biotechnology names. SLS ranks #4 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
224 | $111,267 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
5,425 | $47,495 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
61 | $38,035 | |
| 4 | SLS |
SELLAS Life Sciences Group, Inc.
This page
|
2,516 | $37,136 | |
| 5 | ARGX |
Argenx SE
|
17 | $15,772 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
700 | $12,579 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
209 | $11,398 | |
| 8 | MRNA |
Moderna, Inc.
|
100 | $7,003 |
All Filings in SLS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,136 | 2,516 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $10,642 | 2,516 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||